Tag:
gene sequencing
Latest Headlines
Latest Headlines
Spurned by Illumina, Roche may be eyeing universities for gene-sequencing tech
Roche ($RHHBY) is bound and determined to boost its presence in the molecular diagnostics business. Days after giving up on its $6.7 billion hostile bid for Illumina ($ILMN), a newspaper is reporting the drugmaker may be turning to intellectual property at three universities in its push to acquire gene-sequencing technology.
Roche's bid for Illumina may be kaput
After an apparently unsuccessful attempt to stack Illumina's board in its favor, Roche appears to be heading toward ending its $51-per-share, $6.7 billion bid for the California company.
Study: DNA sequencing dubious as disease prevention tool
DNA sequencing may not be so useful after all for determining future health risks and ways to prevent them, according to a new Johns Hopkins University study.
Swiss report: Roche may abandon Illumina bid
Just a few days after Roche ($RHHBY) upped its offer for Illumina ($ILMN) to nearly $6.7 billion, the Swiss drug giant may abandon its bid, according to a Swiss newspaper account.
Roche pressures Illumina with higher, $6.7B offer
Swiss drug giant Roche has upped its offer for the San Diego-based gene sequencing company Illumina to nearly $6.7 billion, or $51 a share.
Roche tries to pressure Illumina to start talking
Illumina ( $ILMN ) isn't the only game in town, and Roche could easily find other companies to acquire that are equally advanced in the gene-sequencing field, Roche ( $RHHBY ) Chairman Franz Humer told his company's shareholders Tuesday.
Roche will nominate Illumina board candidates
Roche ( $RHHBY ) has upped the ante in its $5.7 billion hostile bid for gene sequencing company Illumina ( $ILMN ). Bloomberg is reporting that the company wants to boost the number of members on
"VAAST" software could spot disease genes
Forbes' Matthew Herper reported that National Human Genome Research Institute recently posted a graphic on Twitter that shows the cost of whole genome sequencing has been falling at a greater pace
Genetic analysis on duty in MGH lab
The cancer center at Massachusetts General Hospital now has a genetic analysis system from Helicos Biosciences. The system incorporates a single-molecule sequencing technology--requiring no DNA
